Advertisement

Hepatobiliäre Funktionsstörungen und Leberversagen

  • Rudolf E. Stauber
  • Peter Fickert
  • Michael Trauner
Chapter
  • 5.8k Downloads

Zusammenfassung

Als »sepsisinduzierte Cholestase« bezeichnet man das Auftreten einer konjugierten Hyperbilirubinämie als Folge einer extrahepatischen bakteriellen Infektion ohne direkte Invasion der Leber durch Erreger.

Literatur

  1. 1.
    Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK (2009) Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 136 (7): 2159–2168PubMedCrossRefGoogle Scholar
  2. 2.
    Als-Nielsen B, Gluud LL, Gluud C (2004) Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 328 (7447): 1046. Epub 2004 Mar 30Google Scholar
  3. 3.
    Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Ketevan P, Garcia-Ruiz E, et al. (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129: 512–521PubMedGoogle Scholar
  4. 4.
    Bernal W, Donaldson N, Wyncoll D, Wendon J (2002) Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 359 (9306): 558–563PubMedCrossRefGoogle Scholar
  5. 5.
    Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L (1995) Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 222 (2): 109–119PubMedCrossRefGoogle Scholar
  6. 6.
    British Committee for Standards in Haematology, Blood Transfusion Task Force (Chairman P. Kelsey) (2003) Guidelines for the use of platelet transfusions. Br J Haematol 122: 10–23Google Scholar
  7. 7.
    Cavicchi M, Beau P, Crenn P, Degott C, Messing B (2000) Prevalence of liver disease and contribution factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 132 (7): 525–532PubMedGoogle Scholar
  8. 8.
    Chung C, Buchman AL (2002) Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction. Clin Liver Dis 6: 1067–84PubMedCrossRefGoogle Scholar
  9. 9.
    Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P (1999) Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29 (3): 648–653PubMedCrossRefGoogle Scholar
  10. 10.
    Cordoba J, Lopez-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F, Esteban R, Guardia J (2004) Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 41 (1): 38–43PubMedCrossRefGoogle Scholar
  11. 11.
    Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35 (3): 716–721PubMedCrossRefGoogle Scholar
  12. 12.
    Fuchs S, Bogomilski-Yahalom V, Platiel O, Ackerman Z (1998) Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol 26 (3): 183–186PubMedCrossRefGoogle Scholar
  13. 13.
    Gibson PR, Dudley FJ (1984) Ischemic hepatitis clinical features, dignosis and prognosis. Aust NZ I Med 14: 822–825Google Scholar
  14. 14.
    Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R (1990) Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 335 (8705): 1572–1573PubMedCrossRefGoogle Scholar
  15. 15.
    Harry R, Auzinger G, Wendon J (2003) The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int 23 (2): 71–77PubMedCrossRefGoogle Scholar
  16. 16.
    Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46 (6):1853–1862PubMedCrossRefGoogle Scholar
  17. 17.
    Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, Loehr M, Liebe S, Mitzner S, Schmidt R, Stange J (2002) Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 36 (4 Pt 1): 949–958PubMedGoogle Scholar
  18. 18.
    Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller F (2003) Hypoxic hepatitis. Clinical and hemodynamic study in 142 consecutive cases. Medicine 82 (6): 392–406PubMedCrossRefGoogle Scholar
  19. 19.
    Jalan R, Damink SW, Deutz NE, Lee A, Hayes PC (1999) Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 354 (9185): 1164–1168PubMedCrossRefGoogle Scholar
  20. 20.
    Jalan R, Williams R (2002) Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 20 (3): 252–61PubMedCrossRefGoogle Scholar
  21. 21.
    Jalan R, Sen S, Williams R (2004) Prospects for extracorporeal liver support. Gut 53 (6): 890–898PubMedCrossRefGoogle Scholar
  22. 22.
    Johnson RD, O´Connor ml, Kerr RM (1995). Extreme serum elevations of aspartate aminotransferase. Am J Gastroenterol 90 (8): 1244–1245PubMedGoogle Scholar
  23. 23.
    Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R, Hendricks R, Kruger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rosch W, Stauch S (1997) Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebocontrolled, double-blind study. Hepatology 25 (6): 1351–1360PubMedCrossRefGoogle Scholar
  24. 24.
    Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG; Austrian Epidemiologic Study on Intensive Care, ASDI Study Group (2007) Incidence and prognosis of early hepatic dysfunction in critically ill patients – a prospective multicenter study. Crit Care Med 354):1099–1104Google Scholar
  25. 25.
    Krisper P, Haditsch B, Stauber R, Jung A, Stadlbauer V, Trauner M, Holzer H, Schneditz D (2005) In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 43: 451–457PubMedCrossRefGoogle Scholar
  26. 26.
    Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, Davern TJ 2nd, Murray NG, McCashland T, Reisch JS, Robuck PR; Acute Liver Failure Study Group (2009) Intravenous N-acetylcysteine improves transplant- free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 137 (3): 856–864Google Scholar
  27. 27.
    Lefkowitch J (1982) Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and »cholangitis lenta«. Human Pathol 13: 19–24CrossRefGoogle Scholar
  28. 28.
    Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362:1071–1081PubMedCrossRefGoogle Scholar
  29. 29.
    Mariat G, Mahul P, Prevot M, De Filippis J, Cuilleron M, Dubois F, et al. (2000) Contribution of ultrasonography and cholescintigraphy to the diagnosis of acute acalculous cholecystitis in intensive care unit patients. Intensive Care Med 26: 1658–1663PubMedCrossRefGoogle Scholar
  30. 30.
    McChesney JA, Northup PG, Bickston SJ (2003) Acute acalculous cholecystitis associated with systemic sepsis and visceral arterial hypoperfusion: a case series and review of pathophysiology. Dig Dis Sci 48 (10): 1960–1970PubMedCrossRefGoogle Scholar
  31. 31.
    Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ et al. (2005) Incidence of drug-induced lliver injury in medical inpatients. Eur J Clin Pharmacol 61 (2): 135–145PubMedCrossRefGoogle Scholar
  32. 32.
    Mitzner S, Klammt S, Stange J, Schmidt R (2006) Albumin regeneration in liver support –comparison of different methods. Ther Apher Dial 10 (2): 108–17PubMedCrossRefGoogle Scholar
  33. 33.
    Moseley RH (2004) Sepsis and cholestasis. Clin Liver Dis 8: 83PubMedCrossRefGoogle Scholar
  34. 34.
    O´Grady JG, Alexander GJ, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97 (2): 439–445Google Scholar
  35. 35.
    O´Grady JG, Schalm SW, Williams R (1993) Acute liver failure: redefining the syndromes. Lancet 342 (8866): 273–275CrossRefGoogle Scholar
  36. 36.
    Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM; U.S. Acute Liver Failure Study Group (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 (12): 947–954Google Scholar
  37. 37.
    Polson J, Lee WM (2005) AASLD position paper: the management of acute liver failure. Hepatology 41: 1179–1197PubMedCrossRefGoogle Scholar
  38. 38.
    Rolando N, Philpott-Howard J, Williams R (1996) Bacterial and fungal infection in acute liver failure. Semin Liver Dis 16 (4): 389–402PubMedCrossRefGoogle Scholar
  39. 39.
    Roslyn JJ, Pitt HA, Mann LL, Ament ME, DenBestenL (1983) Gallbladder disease in patients on long-term parenteral nutrition. Gastroenterology 84: 148–154PubMedGoogle Scholar
  40. 40.
    Ruemmele P, Hofstaedter F, Gelbmann CM; Medscape (2009) Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 6 (5): 287–295Google Scholar
  41. 41.
    Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56 (9): 1310–1318PubMedGoogle Scholar
  42. 42.
    Seeto RK, Fenn B, Rockey DC (2000) Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 109 (2): 109–113PubMedCrossRefGoogle Scholar
  43. 43.
    Sharma P, Kumar A, Shrama BC, Sarin SK (2008) An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am J Gastroenterol 103 (7): 1689–1697PubMedCrossRefGoogle Scholar
  44. 44.
    Sharma BC, Sharma P, Agrawal A, Sarin SK (2009) Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 137 (3): 885–891PubMedCrossRefGoogle Scholar
  45. 45.
    Stravitz RT, Larsen FS (2009) Therapeutic hypothermia for acute liver failure. Crit Care Med 37 (7 Suppl): S258–S264PubMedCrossRefGoogle Scholar
  46. 46.
    Strazzabosco M, Fabris L, Spirli C (2005) Pathophysiology of cholangiopathies. J Clin Gastroenterol 39, Suppl 2: 90–102CrossRefGoogle Scholar
  47. 47.
    Towbridge RL, Rutkowski NK, Shojania KG (2003) Does the patient have acute cholecystitis? JAMA 289 (1): 80–86CrossRefGoogle Scholar
  48. 48.
    Trauner M, Fickert P, Stauber RE (1999) Inflammation-induced cholestasis. J Gastroenterol Hepatol 14 (10): 946–959PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Rudolf E. Stauber
    • 1
  • Peter Fickert
    • 2
  • Michael Trauner
    • 3
  1. 1.Klin. Abt. für Gastroenterologie u. HepatologieMedizinische Universitätsklinik der Universität GrazGraz
  2. 2.Medizinische Universitätsklinik Klinische Abt. für Gastroenterologie u. HepatologieUniversität GrazGraz
  3. 3.Klinische Abt. für Gastroenterologie und Hepatologie, Universitätsklinik für Innere Medizin IIIAKH Universitätscampus WienWien

Personalised recommendations